Journal
INFECTIOUS DISEASES IN CLINICAL PRACTICE
Volume 28, Issue 6, Pages 324-326Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/IPC.0000000000000941
Keywords
SARS CoV-2; COVID-19; type 1 interferon; type 3 interferon
Categories
Ask authors/readers for more resources
Much of COVID-19 disease can be attributed to the stable structure of the envelope, which facilitates its transmission; the spike protein and its receptor which determine which tissues get infected and are susceptible to viral and immune cytolysis; and evasion of initiation of type 1 and 3 interferons, which gives the virus a replicative head start and ability to spread while simultaneously compromising the antiviral immune response.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available